s physico-chemical parameters were optimized to improve lovastatin. Moreover, chemical mutation was systematically employed to enhance lovastatin yield on selected strains. Productivity of 3 ± 0.06 mg lovastatin/gm dfm was obtained prior to optimization. One factor a time followed by Response Surface Methodology (RSM) gave 4.2 ± 0.10 mg lovastatin/gm dfm yield in an optimized setup with pomegranate seed powder (5 gms), KH2PO4 (0.1% w/v), glucose (5% w/v), moisture (60% w/w), pH 5 in a 15 days fermentation cycle. The production was further increased to 6.5 ± 0.08 mg lovastatin/gm dfm through chemical mutation of the strain. This process is simple and reproducible for the production of lovastatin using pomegranate seed as an agro-industrial waste.

KEYWORDS

Lovastatin, Pomegranate Seeds; Solid Substrate Fermentation; Aspergillus Terreus

Cite this paper

Naik, A. and Lele, S. (2012) Solid state fermentation of pomegranate seed for lovastatin production: a bioprocessing approach. Advances in Bioscience and Biotechnology, 3, 643-647. doi: 10.4236/abb.2012.35083.

Cited by

[1] From Pomegranate Processing By-Products to Innovative value added Func-tional Ingredients and Bio-Based Products with Several Applications in Food …
2017
[2] Lovastatin Production by Aspergillus terreus (KM017963) in Submerged and Solid State Fermentation: A Comparative Study
2015
[3] Optimization of Fermentation conditions for higher Monacolin K production by Monascus purpureus
2013

ABB Subscription
E-Mail Alert
ABB Most popular papers
Publication Ethics & OA Statement
ABB News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.